Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia
Damon A Bell,1–3 Amanda J Hooper,1,2,4 Gerald F Watts,2,3 John R Burnett1–41Department of Core Clinical Pathology and Biochemistry, PathWest Laboratory Medicine, 2School of Medicine and Pharmacology, 3Lipid Disorders Clinic, Department of Internal Medicine, Royal Perth Ho...
Main Authors: | Bell DA, Hooper AJ, Watts GF, Burnett JR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-11-01
|
Series: | Vascular Health and Risk Management |
Online Access: | http://www.dovepress.com/mipomersen-and-other-therapies-for-the-treatment-of-severe-familial-hy-a11625 |
Similar Items
-
Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy.
by: Mary P McGowan, et al.
Published: (2012-01-01) -
The Effect of Mipomersen in the Management of Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Clinical Trials
by: Behrooz Astaneh, et al.
Published: (2021-07-01) -
Mipomersen, an apolipoprotein B synthesis inhibitor : A literature study analyzing efficacy and safety when used for treating patients with familial hypercholesterolemia
by: Fernando, Cathrine
Published: (2019) -
Effects of mipomersen, an apolipoprotein B100 antisense, on lipoprotein (a) metabolism in healthy subjects
by: Renu Nandakumar, et al.
Published: (2018-12-01) -
Extracorporeal LDL-Cholesterol Elimination in the Treatment of Severe Familial Hypercholesterolemia
by: Milan Bláha
Published: (2003-01-01)